<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390854</url>
  </required_header>
  <id_info>
    <org_study_id>blood clot/ PRF &amp; regeneration</org_study_id>
    <nct_id>NCT04390854</nct_id>
  </id_info>
  <brief_title>Efficacy of Combined Blood Clot and Platelet Rich Fibrin Scaffolds in Regeneration of Necrotic Immature Permanent Teeth</brief_title>
  <official_title>Efficacy of Combined Blood Clot and Platelet Rich Fibrin Scaffolds in Regeneration of Necrotic Immature Permanent Teeth (A Randomized Controlled Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nourhan M.Aly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alexandria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to assess clinically and radio-graphically the regenerative
      potential of immature permanent teeth with necrotic pulp using blood clot and Platelet rich
      fibrin scaffolds.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      30 immature necrotic permanent teeth in patients will be allocated and divided into two
      groups. Group 1 will be treated by regenerative procedure using blood clot as a scaffold and
      Group 2 will be treated with regenerative procedures using combined blood clot and Platelet
      rich fibrin as a scaffold.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 6, 2018</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Actual">January 20, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The radiographic specialist and the statistician will be blinded to treatment group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective pain assessment</measure>
    <time_frame>1 month</time_frame>
    <description>The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective pain assessment</measure>
    <time_frame>3 months</time_frame>
    <description>The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective pain assessment</measure>
    <time_frame>6 months</time_frame>
    <description>The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective pain assessment</measure>
    <time_frame>12 months</time_frame>
    <description>The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of pulp vitality</measure>
    <time_frame>1 month</time_frame>
    <description>Pulp vitality will be assessed using thermal and electric pulp sensibility tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of pulp vitality</measure>
    <time_frame>3 months</time_frame>
    <description>Pulp vitality will be assessed using thermal and electric pulp sensibility tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of pulp vitality</measure>
    <time_frame>6 months</time_frame>
    <description>Pulp vitality will be assessed using thermal and electric pulp sensibility tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of pulp vitality</measure>
    <time_frame>12 months</time_frame>
    <description>Pulp vitality will be assessed using thermal and electric pulp sensibility tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of root development</measure>
    <time_frame>1 month</time_frame>
    <description>Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of root development</measure>
    <time_frame>3 months</time_frame>
    <description>Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of root development</measure>
    <time_frame>6 months</time_frame>
    <description>Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of root development</measure>
    <time_frame>12 months</time_frame>
    <description>Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>1 month</time_frame>
    <description>Size of the lesion will be assessed using the periapical index score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>1 month</time_frame>
    <description>Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>3 months</time_frame>
    <description>Size of the lesion will be assessed using the periapical index (PAI) score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>3 months</time_frame>
    <description>Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>6 months</time_frame>
    <description>Size of the lesion will be assessed using the periapical index (PAI) score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>6 months</time_frame>
    <description>Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>12 months</time_frame>
    <description>Size of the lesion will be assessed using the periapical index (PAI) score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of the size of periapical radiolucency</measure>
    <time_frame>12 months</time_frame>
    <description>Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pulp Necroses</condition>
  <arm_group>
    <arm_group_label>Induced blood clot scaffold</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Induced blood clot scaffold combined with Platelet rich fibrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood clot scaffold</intervention_name>
    <description>Bleeding will be induced in the canal by passing a size 30 sterile K-file 3 mm beyond the apex with the goal of having the entire canal filled with blood to the level of the cemento-enamel junction. Bleeding will be stopped just below the cemento enamel junction.
Biodentine will be placed approximately 3-4 mm below the cementoenamel junction.</description>
    <arm_group_label>Induced blood clot scaffold</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood clot scaffold combined with PRF</intervention_name>
    <description>Platelet-rich fibrin will be prepared by drawing the patient blood into a 10mL test tube without the addition of an anticoagulant. To prevent the blood from coagulating after coming in contact with the glass tube, it will be centrifuged immediately using a table top centrifuge** at 400 g force for 12 minutes. Then platelet-rich fibrin membrane will be placed into the canal space to a level 3 mm below the cemento-enamel junction using hand plugger following the induction of apical bleeding by passing a number 30 sterile hand file 3 mm beyond the apex of the tooth. Biodentine cap will be placed over the platelet-rich fibrin scaffold.</description>
    <arm_group_label>Induced blood clot scaffold combined with Platelet rich fibrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Necrotic incisors with immature roots

          -  Pulp space not needed for post and core.

          -  The patient has to be free from any coagulation disorders, with normal platelets
             count.

          -  Good oral hygiene

          -  Cooperative patient

        Exclusion Criteria:

          -  Internal or external root resorption.

          -  Root fracture and/or alveolar fracture.

          -  Previous root canal treatment.

          -  Medically compromised patients

          -  Uncooperative patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud MS Hassan, M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Ibrahim, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sybel M Moussa, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nihal A Lehita, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry, Alexandria University</name>
      <address>
        <city>Alexandria</city>
        <zip>21512</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Bakhtiar H, Vatanpour M, Rayani A, Navi F, Asna-Ashari E, Ahmadi A, Jafarzadeh H. The plasma-rich in growth factor as a suitable matrix in regenerative endodontics: a case series. N Y State Dent J. 2014 Jun-Jul;80(4):49-53.</citation>
    <PMID>25219066</PMID>
  </reference>
  <reference>
    <citation>Keswani D, Pandey RK. Revascularization of an immature tooth with a necrotic pulp using platelet-rich fibrin: a case report. Int Endod J. 2013 Nov;46(11):1096-104. doi: 10.1111/iej.12107. Epub 2013 Apr 13.</citation>
    <PMID>23581794</PMID>
  </reference>
  <reference>
    <citation>Yassen GH, Eckert GJ, Platt JA. Effect of intracanal medicaments used in endodontic regeneration procedures on microhardness and chemical structure of dentin. Restor Dent Endod. 2015 May;40(2):104-12. doi: 10.5395/rde.2015.40.2.104. Epub 2014 Dec 24.</citation>
    <PMID>25984471</PMID>
  </reference>
  <reference>
    <citation>Yassen GH, Sabrah AH, Eckert GJ, Platt JA. Effect of different endodontic regeneration protocols on wettability, roughness, and chemical composition of surface dentin. J Endod. 2015 Jun;41(6):956-60. doi: 10.1016/j.joen.2015.02.023. Epub 2015 Mar 29.</citation>
    <PMID>25823403</PMID>
  </reference>
  <reference>
    <citation>Neha K, Kansal R, Garg P, Joshi R, Garg D, Grover HS. Management of immature teeth by dentin-pulp regeneration: a recent approach. Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16(7):e997-1004. Review.</citation>
    <PMID>21743418</PMID>
  </reference>
  <reference>
    <citation>Lovelace TW, Henry MA, Hargreaves KM, Diogenes A. Evaluation of the delivery of mesenchymal stem cells into the root canal space of necrotic immature teeth after clinical regenerative endodontic procedure. J Endod. 2011 Feb;37(2):133-8. doi: 10.1016/j.joen.2010.10.009.</citation>
    <PMID>21238791</PMID>
  </reference>
  <reference>
    <citation>Cotti E, Mereu M, Lusso D. Regenerative treatment of an immature, traumatized tooth with apical periodontitis: report of a case. J Endod. 2008 May;34(5):611-6. doi: 10.1016/j.joen.2008.02.029.</citation>
    <PMID>18436046</PMID>
  </reference>
  <reference>
    <citation>Cehreli ZC, Isbitiren B, Sara S, Erbas G. Regenerative endodontic treatment (revascularization) of immature necrotic molars medicated with calcium hydroxide: a case series. J Endod. 2011 Sep;37(9):1327-30. doi: 10.1016/j.joen.2011.05.033. Epub 2011 Jul 13.</citation>
    <PMID>21846559</PMID>
  </reference>
  <reference>
    <citation>Law AS. Considerations for regeneration procedures. J Endod. 2013 Mar;39(3 Suppl):S44-56. doi: 10.1016/j.joen.2012.11.019. Review.</citation>
    <PMID>23439044</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Alexandria</investigator_affiliation>
    <investigator_full_name>Nourhan M.Aly</investigator_full_name>
    <investigator_title>Teaching Assistant of Dental Public Health and Statistician</investigator_title>
  </responsible_party>
  <keyword>Regenerative endodontics</keyword>
  <keyword>Open apex</keyword>
  <keyword>Immature necrotic teeth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Pulp Necrosis</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clotrimazole</mesh_term>
    <mesh_term>Miconazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

